Table 3.

Direct diabetes-related pharmacy costs

	Before V-Go	On V-Go
	All patients N = 97	All patients N = 97	Patients with no change to NIGLM N = 52	Patients with increase to NIGLM N = 23	Patients with decrease to NIGLM N = 16
Pharmacy costs PPPM a PPPM
Non-insulin agentsb	$175.60	$203.00	$104.50	$433.10	$80.10
Insulin TDD costsc	$788.80	$403.00	$369.90	$487.40	$386.90
Syringe/pen needlesd	$24.49	$0.63		$2.34
V-Go device	–	$262.94	$262.94	$262.94	$262.94
Total therapy costs	$988.89	$869.57	$737.34	$1185.78	$729.94

NIGLM non-insulin glucose-lowering medications, PPPM per patient per month, TDD insulin total daily dose, WAC wholesale acquisition costs

^aCosts based on WAC pricing (US $) for specific brand and dose of medication

^bCosts not included for generic medications (metformin, sulfonylurea, and metformin/sulfonylurea)

^cInsulin costs are normalized by multiplying the prescribed TDD in units by the unit price and converted to a 30-day monthly cost

^dSyringe/pen needles based on 1/day for patients administering basal only insulin and 3/day for patients administering multiple daily injections before V-Go and as applicable for supplemental insulin using V-Go